… in the Ocular Hypertension Treatment Study developed visual field loss in either eye over
long-… This information, together with a prediction model, may help clinicians and patients make …

… To compare visual field outcomes of ocular hypertensive and glaucoma patients treated
first with medical therapy with those treated first with selective laser trabeculoplasty (SLT). …

… of drawing a distinction between glaucoma and ocular hypertension without evidence of
glaucomatous damage. This is because eye trauma can make the structural and functional …

… optic neuropathy and visual field loss with or without raised intraocular pressure (IOP).1 …
account for why some patients are susceptible to glaucomatous damage even under normal …

… field loss with mean deviation (VF MD) not worse than −12 decibels (dB) in the better eye
or −15 dB in the worse eye, and, for OAG, corresponding damage to the optic nerve head. …

… not to enter the eye (10%); and difficulty squeezing the bottle (5%) [Citation38]. Over a 12-week
study (n = 164), 42% of patients with glaucoma or ocular hypertension were observed to …

… In this observer-masked, randomised controlled trial treatment-naive patients with open
angle glaucoma or ocular hypertension and no ocular comorbidities were recruited between …

… In 2019, the LiGHT Trial reported that initial treatment of ocular hypertension (OHT) or open-…
-lowering eye drops after 3 years, while also providing drop freedom to 74.2% of patients, a …

… Central corneal thickness has been referred to as an independent risk factor for the conversion
of ocular hypertension to glaucoma 49 and glaucoma progression. However, CCT is a …

… To evaluate the intraocular pressure (IOP)-lowering efficacy and safety of 10- and 15-μg
bimatoprost implant in subjects with open-angle glaucoma (OAG) and ocular hypertension (OHT…